The Future of Alzheimer’s Prevention
Atria.org / Health Education / The Future of Alzheimer’s Prevention
Dr. Richard Isaacson is transforming the way we think about Alzheimer’s prevention. A trailblazer in the field, he shares how genetic insights and personalized strategies are reshaping early intervention—offering hope where there once was uncertainty.
About the episode
In this episode of Atria’s Vanguard Symposia, pioneering neurologist Dr. Richard Isaacson discusses the future of Alzheimer's prevention, highlighting his cutting-edge research and the crucial role of personalized medicine. Dr. Isaacson explains how researchers can now use genetic data and risk factors to design individualized care plans, benefiting high-risk individuals earlier. He takes listeners through the ways that genetic predispositions inform prevention strategies and outlines evidence-based interventions that are being used to develop a robust preventive framework. The conversation covers emerging technologies like digital health tracking, cognitive monitoring, and non-invasive diagnostic testing, which are bringing us into a new era of Alzheimer's prevention.
About the series
Atria’s Vanguard Symposia is a lecture series where some of the world’s most compelling researchers translate leading-edge science into medicine. In each episode, top experts share breakthrough science about preventive health care, dive deep into headline-grabbing topics, and take you beyond the buzzwords to explain the latest in longevity science. Our show will arm you with practical information and the tools of discernment to cut through the hype and understand what matters most.
Atria Health and Research Institute aims to accelerate a global shift from reactive sick care to proactive, preventive health care. We work at the forefront of science and technology and we believe a collaborative approach to modern medicine can extend healthy life for all.
Read more
What to Know About Psilocybin Therapy for Mental Health
Article
Brain health
Mind body
Proponents of psychedelic drugs have been touting their benefits for various mental health conditions for more than half a century. Now, psilocybin—the active ingredient in so-called magic mushrooms—is getting more attention as real-world and clinical trial evidence shows promising results. The field sees promise in the hallucinogenic drug, but many obstacles remain.
Can a Simple Mineral Protect Against Alzheimer’s?
Article
Longevity
Brain health
The findings are genuinely exciting, but well-controlled human trials—especially using potentially safer forms like lithium orotate—are essential before any medical recommendations can be made. Until then, while lithium shows exciting promise in lab and animal studies, it's not ready for primetime.
The Science of Creatine Supplements
Article
Performance & movement
Brain health
Bone health
Based on the mounting evidence, it appears creatine isn’t just for bodybuilders anymore. For more than two decades, scientists have studied this compound for its potential benefits for increasing muscle mass and preventing muscle loss, among other things. More recent studies have investigated its usefulness in improving memory, and there’s even intriguing, though preliminary, research that creatine may play a role in supporting mental health in people with depression.
Sorry no results match your query